Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2026-04-18 @ 4:25 AM
Study NCT ID:
NCT00783692
Status:
COMPLETED
Last Update Posted:
2014-07-21
First Post:
2008-10-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C13007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None